As April winds down and major German chemical companies hold their annual shareholder meetings, questions are being asked whether about the country is tying its trade too...
Shares of Prometheus Biosciences soared on news that US drugs major Merck will acquire the company in an all-cash deal valued at roughly $200 per share, or $10.8 billion...
Germany’s Merck plans to invest some €300 million in an integrated specialty gas plant in Hometown, Pennsylvania, to support the development of its semiconductor business...
Germany’s Merck will regain exclusive worldwide rights to develop, manufacture and commercialize the anti-programmed death ligand-1 (PD-L1) antibody Bavencio (avelumab)...
German chemicals, pharmaceuticals and life sciences group Merck and US semiconductors giant Intel have signed a letter of intent to fund a European academic research...
Germany‘s Merck has granted an exclusive license for the tumor-targeting IL-12 fusion protein currently known as M9241 to PDS Biotechnology Corporation, a US-based...
Germany’s Merck has acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. Financial terms were not disclosed. The...
In a move to advance productivity, the healthcare division of Germany’s Merck is realigning its drug discovery and launch strategy. Global healthcare research chief Danny...
